Randall C. Schatzman, President and CEO at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 20,000 shares at $29.51 ($593K) on 2016-06-01, disclosed to the SEC on 2016-06-03.
Open-market sale of $593k ALDR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.51 | 8,035 | $237K | 40.0% |
| 2 | $29.51 | 8,035 | $237K | 40.0% |
| 3 | $30.26 | 1,965 | $59K | 10.0% |
| 4 | $30.26 | 1,965 | $59K | 10.0% |
| Total | $29.66 avg | 20,000 | $593K | 100% |
| Filing → |
| ALDR | SELL | 2016-11-09 | $252K | — | Filing → |
| ALDR | SELL | 2016-10-05 | $424K | — | Filing → |
| ALDR | SELL | 2016-09-06 | $650K | — | Filing → |